path;tool_version;run_settings;plasmodb_ac;title;abstract;entity_desc;has_ab;mdl_rank;ncbi_taxonomic_ID;MA_ID
ModelArchive AF2\AF2_CSP_clinical_isolates\101_Nyamisati_1999_Tanzania_lib12_Plate2_E1_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_101_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-001
ModelArchive AF2\AF2_CSP_clinical_isolates\104_Nyamisati_1999_Tanzania_lib12_Plate2_H1_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_104_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-002
ModelArchive AF2\AF2_CSP_clinical_isolates\104_Nyamisati_1999_Tanzania_lib12_Plate2_H1_3_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_104_Nya1999_3_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-003
ModelArchive AF2\AF2_CSP_clinical_isolates\114_Nyamisati_1999_Tanzania_lib12_Plate2_B3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_114_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-004
ModelArchive AF2\AF2_CSP_clinical_isolates\116_Nyamisati_1999_Tanzania_lib12_Plate2_D3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_116_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-005
ModelArchive AF2\AF2_CSP_clinical_isolates\119_Nyamisati_1999_Tanzania_lib12_Plate2_G3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_119_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-006
ModelArchive AF2\AF2_CSP_clinical_isolates\122_Nyamisati_1999_Tanzania_lib12_Plate2_B4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_122_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-007
ModelArchive AF2\AF2_CSP_clinical_isolates\122_Nyamisati_1999_Tanzania_lib12_Plate2_B4_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_122_Nya1999_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-008
ModelArchive AF2\AF2_CSP_clinical_isolates\127_Nyamisati_1999_Tanzania_lib12_Plate2_G4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_127_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-009
ModelArchive AF2\AF2_CSP_clinical_isolates\130_Nyamisati_1994_Tanzania_lib12_Plate2_B5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_130_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-010
ModelArchive AF2\AF2_CSP_clinical_isolates\131_Nyamisati_1994_Tanzania_lib12_Plate2_C5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_131_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-011
ModelArchive AF2\AF2_CSP_clinical_isolates\132_Nyamisati_1994_Tanzania_lib12_Plate2_D5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_132_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-012
ModelArchive AF2\AF2_CSP_clinical_isolates\133_Nyamisati_1994_Tanzania_lib12_Plate2_E5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_133_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-013
ModelArchive AF2\AF2_CSP_clinical_isolates\135_Nyamisati_1994_Tanzania_lib12_Plate2_G5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_135_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-014
ModelArchive AF2\AF2_CSP_clinical_isolates\136_Nyamisati_1994_Tanzania_lib12_Plate2_H5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_136_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-015
ModelArchive AF2\AF2_CSP_clinical_isolates\138_Nyamisati_1994_Tanzania_lib12_Plate2_B6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_138_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-016
ModelArchive AF2\AF2_CSP_clinical_isolates\139_Nyamisati_1994_Tanzania_lib12_Plate2_C6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_139_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-017
ModelArchive AF2\AF2_CSP_clinical_isolates\139_Nyamisati_1994_Tanzania_lib12_Plate2_C6_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_139_Nya1994_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-018
ModelArchive AF2\AF2_CSP_clinical_isolates\140_Nyamisati_1994_Tanzania_lib12_Plate2_D6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_140_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-019
ModelArchive AF2\AF2_CSP_clinical_isolates\141_Nyamisati_1994_Tanzania_lib12_Plate2_E6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_141_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-020
ModelArchive AF2\AF2_CSP_clinical_isolates\142_Nyamisati_1994_Tanzania_lib12_Plate2_F6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_142_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-021
ModelArchive AF2\AF2_CSP_clinical_isolates\143_Nyamisati_1994_Tanzania_lib12_Plate2_G6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_143_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-022
ModelArchive AF2\AF2_CSP_clinical_isolates\144_Nyamisati_1994_Tanzania_lib12_Plate2_H6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_144_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-023
ModelArchive AF2\AF2_CSP_clinical_isolates\155_Nyamisati_1994_Tanzania_lib12_Plate2_C8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_155_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-024
ModelArchive AF2\AF2_CSP_clinical_isolates\160_Nyamisati_1994_Tanzania_lib12_Plate2_H8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_160_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-025
ModelArchive AF2\AF2_CSP_clinical_isolates\17_Nyamisati_2016_Tanzania_lib12_Plate1_A3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_17_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced using method described in Plaza DF et al 2023 (PMID: 37751696) and deposited in ENA as ... lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced using method described in Plaza DF et al 2023 (PMID: 37751696) and deposited in ENA as ... lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-026
ModelArchive AF2\AF2_CSP_clinical_isolates\184_Nyamisati_1994_Tanzania_lib12_Plate2_H11_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_184_Nya1994__1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-027
ModelArchive AF2\AF2_CSP_clinical_isolates\188_Nyamisati_1994_Tanzania_lib12_Plate2_D12_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_188_Nya1994__1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-028
ModelArchive AF2\AF2_CSP_clinical_isolates\193_Nyamisati_2016_Tanzania_lib12_Plate3_A1_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_193_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-029
ModelArchive AF2\AF2_CSP_clinical_isolates\196_Nyamisati_2016_Tanzania_lib12_Plate3_D1_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_196_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-030
ModelArchive AF2\AF2_CSP_clinical_isolates\197_Nyamisati_1994_Tanzania_lib12_Plate3_E1_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_197_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-031
ModelArchive AF2\AF2_CSP_clinical_isolates\202_Nyamisati_2016_Tanzania_lib12_Plate3_B2_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_202_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-032
ModelArchive AF2\AF2_CSP_clinical_isolates\205_Nyamisati_1994_Tanzania_lib12_Plate3_E2_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_205_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-033
ModelArchive AF2\AF2_CSP_clinical_isolates\208_Nyamisati_2016_Tanzania_lib12_Plate3_H2_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_208_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-034
ModelArchive AF2\AF2_CSP_clinical_isolates\21_Nyamisati_1994_Tanzania_lib12_Plate1_E3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_21_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced using method described in Plaza DF et al 2023 (PMID: 37751696) and deposited in ENA as ... lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced using method described in Plaza DF et al 2023 (PMID: 37751696) and deposited in ENA as ... lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-035
ModelArchive AF2\AF2_CSP_clinical_isolates\219_Nyamisati_2016_Tanzania_lib12_Plate3_C4_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_219_Nya2016_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-036
ModelArchive AF2\AF2_CSP_clinical_isolates\22_Nyamisati_1994_Tanzania_lib12_Plate1_F3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_22_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-037
ModelArchive AF2\AF2_CSP_clinical_isolates\221_Nyamisati_1994_Tanzania_lib12_Plate3_E4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_221_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-038
ModelArchive AF2\AF2_CSP_clinical_isolates\222_Nyamisati_1994_Tanzania_lib12_Plate3_F4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_222_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-039
ModelArchive AF2\AF2_CSP_clinical_isolates\223_Nyamisati_2016_Tanzania_lib12_Plate3_G4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_223_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-040
ModelArchive AF2\AF2_CSP_clinical_isolates\224_Nyamisati_2016_Tanzania_lib12_Plate3_H4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_224_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-041
ModelArchive AF2\AF2_CSP_clinical_isolates\23_Nyamisati_2016_Tanzania_lib12_Plate1_G3_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_23_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-042
ModelArchive AF2\AF2_CSP_clinical_isolates\251_Nyamisati_2016_Tanzania_lib12_Plate3_C8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_251_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-043
ModelArchive AF2\AF2_CSP_clinical_isolates\252_Nyamisati_1994_Tanzania_lib12_Plate3_D8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_252_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-044
ModelArchive AF2\AF2_CSP_clinical_isolates\257_Nyamisati_2016_Tanzania_lib12_Plate3_A9_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_257_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-045
ModelArchive AF2\AF2_CSP_clinical_isolates\259_Nyamisati_2016_Tanzania_lib12_Plate3_C9_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_259_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-046
ModelArchive AF2\AF2_CSP_clinical_isolates\276_Nyamisati_1994_Tanzania_lib12_Plate3_D11_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_276_Nya1994__2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-047
ModelArchive AF2\AF2_CSP_clinical_isolates\298_Nyamisati_1999_Tanzania_lib12_Plate4_B2_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_298_Nya1999_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-048
ModelArchive AF2\AF2_CSP_clinical_isolates\301_Nyamisati_1999_Tanzania_lib12_Plate4_E2_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_301_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-049
ModelArchive AF2\AF2_CSP_clinical_isolates\301_Nyamisati_1999_Tanzania_lib12_Plate4_E2_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_301_Nya1999_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-050
ModelArchive AF2\AF2_CSP_clinical_isolates\315_Nyamisati_1999_Tanzania_lib12_Plate4_C4_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_315_Nya1999_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-051
ModelArchive AF2\AF2_CSP_clinical_isolates\33_Nyamisati_2016_Tanzania_lib12_Plate1_A5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_33_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-052
ModelArchive AF2\AF2_CSP_clinical_isolates\34_Nyamisati_2016_Tanzania_lib12_Plate1_B5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_34_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-053
ModelArchive AF2\AF2_CSP_clinical_isolates\341_Nyamisati_1994_Tanzania_lib12_Plate4_E7_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_341_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-054
ModelArchive AF2\AF2_CSP_clinical_isolates\357_Nyamisati_1994_Tanzania_lib12_Plate4_E9_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_357_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-055
ModelArchive AF2\AF2_CSP_clinical_isolates\37_Nyamisati_1994_Tanzania_lib12_Plate1_E5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_37_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-056
ModelArchive AF2\AF2_CSP_clinical_isolates\38_Nyamisati_1994_Tanzania_lib12_Plate1_F5_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_38_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-057
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_3d7_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-058
ModelArchive AF2\AF2_CSP_clinical_isolates\41_Nyamisati_2016_Tanzania_lib12_Plate1_A6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_41_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-059
ModelArchive AF2\AF2_CSP_clinical_isolates\42_Nyamisati_2016_Tanzania_lib12_Plate1_B6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_42_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-060
ModelArchive AF2\AF2_CSP_clinical_isolates\44_Nyamisati_1994_Tanzania_lib12_Plate1_D6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_44_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-061
ModelArchive AF2\AF2_CSP_clinical_isolates\44_Nyamisati_1994_Tanzania_lib12_Plate1_D6_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_44_Nya1994_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-062
ModelArchive AF2\AF2_CSP_clinical_isolates\46_Nyamisati_1994_Tanzania_lib12_Plate1_F6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_46_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-063
ModelArchive AF2\AF2_CSP_clinical_isolates\47_Nyamisati_2016_Tanzania_lib12_Plate1_G6_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_47_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-064
ModelArchive AF2\AF2_CSP_clinical_isolates\48_Nyamisati_1994_Tanzania_lib12_Plate1_H6_3_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_48_Nya1994_3_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-065
ModelArchive AF2\AF2_CSP_clinical_isolates\48_Nyamisati_1994_Tanzania_lib12_Plate1_H6_4_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_48_Nya1994_4_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-066
ModelArchive AF2\AF2_CSP_clinical_isolates\58_Nyamisati_2016_Tanzania_lib12_Plate1_B8_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_58_Nya2016_2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-067
ModelArchive AF2\AF2_CSP_clinical_isolates\58_Nyamisati_2016_Tanzania_lib12_Plate1_B8_4_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_58_Nya2016_4_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-068
ModelArchive AF2\AF2_CSP_clinical_isolates\62_Nyamisati_2016_Tanzania_lib12_Plate1_F8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_62_Nya2016_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-069
ModelArchive AF2\AF2_CSP_clinical_isolates\64_Nyamisati_1994_Tanzania_lib12_Plate1_H8_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_64_Nya1994_1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-070
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_7g8_af3_model_0;Alphafold3 (server);"Default; Seed Auto";Pf7G8-2_000074100;CSP_7g8_model_0;Model generated with Alphafold3 (server) for CSP reference variant (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-071
ModelArchive AF2\AF2_CSP_clinical_isolates\81_Nyamisati_2016_Tanzania_lib12_Plate1_A11_2_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_81_Nya2016__2_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-072
ModelArchive AF2\AF2_CSP_clinical_isolates\86_Nyamisati_1994_Tanzania_lib12_Plate1_F11_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_86_Nya1994__1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-073
ModelArchive AF2\AF2_CSP_clinical_isolates\88_Nyamisati_2016_Tanzania_lib12_Plate1_H11_1_1;Alphafold 2.3.2+Galaxy0;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;CSP_88_Nya2016__1_1;Model generated with Alphafold 2.3.2+Galaxy0 for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) ;N;1;5833;ma-csp-msp2-074
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_gn01_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PfGN01_030010200;CSP_gn01_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PfGN01_030010200) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PfGN01_030010200) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-075
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_ke01_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PfKE01_030009000;CSP_ke01_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PfKE01_030009000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PfKE01_030009000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-076
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_nf166_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PfNF166_030008000;CSP_nf166_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PfNF166_030008000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PfNF166_030008000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-077
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_padleri_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PADL01_0303400;CSP_padleri_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PADL01_0303400) lacking its predicted signal peptide (MRNLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PADL01_0303400) lacking its predicted signal peptide (MRNLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;880535;ma-csp-msp2-078
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_pblacklockig01_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PBLACG01_0304600;CSP_pblacklockig01_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PBLACG01_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PBLACG01_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;880536;ma-csp-msp2-079
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_ppraefalcipaarumg01_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PPRFG01_0305900;CSP_ppraefalcipaarumg01_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PPRFG01_0305900) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PPRFG01_0305900) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;880534;ma-csp-msp2-080
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_preichenowi_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PRCDC_0303900;CSP_preichenowi_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PRCDC_0303900) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PRCDC_0303900) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5854;ma-csp-msp2-081
ModelArchive AF3\AF3_CSP_reference_variants_orthologs\fold_csp_tg01_af3_model_0;Alphafold3 (server);"Default; Seed Auto";PfTG01_030011000;CSP_tg01_model_0;Model generated with Alphafold3 (server) for CSP reference variant (PfTG01_030011000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);CSP reference variant (PfTG01_030011000) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);N;1;5833;ma-csp-msp2-082
ModelArchive AF2\AF2_MSP2_clinical_isolates\101_Nyamisati_1999_Tanzania_lib12_Plate2_E1_ICR_437._V_1;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_101_Nya_1999_ICR_437_V1;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-083
ModelArchive AF2\AF2_MSP2_clinical_isolates\104_Nyamisati_1999_Tanzania_lib12_Plate2_H1_ICR_516._V_2;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_104_Nya_1999_ICR_516_V2;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-084
ModelArchive AF2\AF2_MSP2_clinical_isolates\106_Nyamisati_1999_Tanzania_lib12_Plate2_B2_FC27R_385._V_3;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_106_Nya_1999_FC27R_385_V3;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-085
ModelArchive AF2\AF2_MSP2_clinical_isolates\109_Nyamisati_1999_Tanzania_lib12_Plate2_E2_FC27R_328._V_4;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_109_Nya_1999_FC27R_328_V4;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-086
ModelArchive AF2\AF2_MSP2_clinical_isolates\114_Nyamisati_1999_Tanzania_lib12_Plate2_B3_ICR_602._V_8;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_114_Nya_1999_ICR_602_V8;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-087
ModelArchive AF2\AF2_MSP2_clinical_isolates\114_Nyamisati_1999_Tanzania_lib12_Plate2_B3_ICR_602._V_9;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_114_Nya_1999_ICR_602_V9;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-088
ModelArchive AF2\AF2_MSP2_clinical_isolates\124_Nyamisati_1999_Tanzania_lib12_Plate2_D4_ICR_455._V_11;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_124_Nya_1999_ICR_455_V11;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-089
ModelArchive AF2\AF2_MSP2_clinical_isolates\124_Nyamisati_1999_Tanzania_lib12_Plate2_D4_ICR_455._V_12;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_124_Nya_1999_ICR_455_V12;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-090
ModelArchive AF2\AF2_MSP2_clinical_isolates\127_Nyamisati_1999_Tanzania_lib12_Plate2_G4_ICR_482._V_15;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_127_Nya_1999_ICR_482_V15;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-091
ModelArchive AF2\AF2_MSP2_clinical_isolates\128_Nyamisati_1994_Tanzania_lib12_Plate2_H4_ICR_578._V_16;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_128_Nya_1994_ICR_578_V16;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-092
ModelArchive AF2\AF2_MSP2_clinical_isolates\13_Nyamisati_1994_Tanzania_lib12_Plate1_E2_FC27R_316._V_21;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_13_Nya_1994_FC27R_316_V21;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-093
ModelArchive AF2\AF2_MSP2_clinical_isolates\135_Nyamisati_1994_Tanzania_lib12_Plate2_G5_ICR_515._V_18;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_135_Nya_1994_ICR_515_V18;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-094
ModelArchive AF2\AF2_MSP2_clinical_isolates\136_Nyamisati_1994_Tanzania_lib12_Plate2_H5_ICR_479._V_19;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_136_Nya_1994_ICR_479_V19;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-095
ModelArchive AF2\AF2_MSP2_clinical_isolates\136_Nyamisati_1994_Tanzania_lib12_Plate2_H5_ICR_515._V_20;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_136_Nya_1994_ICR_515_V20;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-096
ModelArchive AF2\AF2_MSP2_clinical_isolates\140_Nyamisati_1994_Tanzania_lib12_Plate2_D6_ICR_620._V_22;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_140_Nya_1994_ICR_620_V22;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-097
ModelArchive AF2\AF2_MSP2_clinical_isolates\148_Nyamisati_1994_Tanzania_lib12_Plate2_D7_FC27R_328._V_23;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_148_Nya_1994_FC27R_328_V23;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-098
ModelArchive AF2\AF2_MSP2_clinical_isolates\151_Nyamisati_1994_Tanzania_lib12_Plate2_G7_ICR_587._V_24;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_151_Nya_1994_ICR_587_V24;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-099
ModelArchive AF2\AF2_MSP2_clinical_isolates\154_Nyamisati_1994_Tanzania_lib12_Plate2_B8_FC27R_328._V_25;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_154_Nya_1994_FC27R_328_V25;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-100
ModelArchive AF2\AF2_MSP2_clinical_isolates\16_Nyamisati_2016_Tanzania_lib12_Plate1_H2_ICR_488._V_31;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_16_Nya_2016_ICR_488_V31;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-101
ModelArchive AF2\AF2_MSP2_clinical_isolates\160_Nyamisati_1994_Tanzania_lib12_Plate2_H8_ICR_737._V_27;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_160_Nya_1994_ICR_737_V27;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-102
ModelArchive AF2\AF2_MSP2_clinical_isolates\168_Nyamisati_1994_Tanzania_lib12_Plate2_H9_FC27R_301._V_28;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_168_Nya_1994_FC27R_301_V28;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-103
ModelArchive AF2\AF2_MSP2_clinical_isolates\168_Nyamisati_1994_Tanzania_lib12_Plate2_H9_ICR_584._V_29;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_168_Nya_1994_ICR_584_V29;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-104
ModelArchive AF2\AF2_MSP2_clinical_isolates\168_Nyamisati_1994_Tanzania_lib12_Plate2_H9_ICR_626._V_30;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_168_Nya_1994_ICR_626_V30;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-105
ModelArchive AF2\AF2_MSP2_clinical_isolates\176_Nyamisati_1994_Tanzania_lib12_Plate2_H10_ICR_578._V_32;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_176_Nya_1994_ICR_578_V32;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-106
ModelArchive AF2\AF2_MSP2_clinical_isolates\176_Nyamisati_1994_Tanzania_lib12_Plate2_H10_ICR_608._V_33;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_176_Nya_1994_ICR_608_V33;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-107
ModelArchive AF2\AF2_MSP2_clinical_isolates\191_Nyamisati_1994_Tanzania_lib12_Plate2_G12_FC27R_376._V_34;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_191_Nya_1994_FC27R_376_V34;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-108
ModelArchive AF2\AF2_MSP2_clinical_isolates\192_Nyamisati_1999_Tanzania_lib12_Plate2_H12_ICR_485._V_36;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_192_Nya_1999_ICR_485_V36;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-109
ModelArchive AF2\AF2_MSP2_clinical_isolates\192_Nyamisati_1999_Tanzania_lib12_Plate2_H12_ICR_509._V_37;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_192_Nya_1999_ICR_509_V37;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-110
ModelArchive AF2\AF2_MSP2_clinical_isolates\196_Nyamisati_2016_Tanzania_lib12_Plate3_D1_ICR_557._V_38;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_196_Nya_2016_ICR_557_V38;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-111
ModelArchive AF2\AF2_MSP2_clinical_isolates\197_Nyamisati_1994_Tanzania_lib12_Plate3_E1_ICR_440._V_39;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_197_Nya_1994_ICR_440_V39;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-112
ModelArchive AF2\AF2_MSP2_clinical_isolates\20_Nyamisati_1994_Tanzania_lib12_Plate1_D3_FC27R_220._V_45;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_20_Nya_1994_FC27R_220_V45;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-113
ModelArchive AF2\AF2_MSP2_clinical_isolates\20_Nyamisati_1994_Tanzania_lib12_Plate1_D3_FC27R_256._V_46;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_20_Nya_1994_FC27R_256_V46;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-114
ModelArchive AF2\AF2_MSP2_clinical_isolates\200_Nyamisati_1994_Tanzania_lib12_Plate3_H1_ICR_731._V_40;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_200_Nya_1994_ICR_731_V40;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-115
ModelArchive AF2\AF2_MSP2_clinical_isolates\204_Nyamisati_2016_Tanzania_lib12_Plate3_D2_ICR_557._V_42;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_204_Nya_2016_ICR_557_V42;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-116
ModelArchive AF2\AF2_MSP2_clinical_isolates\212_Nyamisati_1994_Tanzania_lib12_Plate3_D3_FC27R_220._V_47;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_212_Nya_1994_FC27R_220_V47;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-117
ModelArchive AF2\AF2_MSP2_clinical_isolates\212_Nyamisati_1994_Tanzania_lib12_Plate3_D3_FC27R_220._V_48;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_212_Nya_1994_FC27R_220_V48;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-118
ModelArchive AF2\AF2_MSP2_clinical_isolates\220_Nyamisati_1994_Tanzania_lib12_Plate3_D4_FC27R_328._V_51;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_220_Nya_1994_FC27R_328_V51;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-119
ModelArchive AF2\AF2_MSP2_clinical_isolates\252_Nyamisati_1994_Tanzania_lib12_Plate3_D8_FC27R_328._V_54;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_252_Nya_1994_FC27R_328_V54;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-120
ModelArchive AF2\AF2_MSP2_clinical_isolates\256_Nyamisati_1994_Tanzania_lib12_Plate3_H8_ICR_521._V_56;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_256_Nya_1994_ICR_521_V56;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-121
ModelArchive AF2\AF2_MSP2_clinical_isolates\260_Nyamisati_1994_Tanzania_lib12_Plate3_D9_FC27R_220._V_57;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_260_Nya_1994_FC27R_220_V57;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-122
ModelArchive AF2\AF2_MSP2_clinical_isolates\260_Nyamisati_1994_Tanzania_lib12_Plate3_D9_FC27R_220._V_58;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_260_Nya_1994_FC27R_220_V58;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-123
ModelArchive AF2\AF2_MSP2_clinical_isolates\272_Nyamisati_1994_Tanzania_lib12_Plate3_H10_ICR_464._V_60;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_272_Nya_1994__ICR_464_V60;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-124
ModelArchive AF2\AF2_MSP2_clinical_isolates\28_Nyamisati_1994_Tanzania_lib12_Plate1_D4_FC27R_328._V_63;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_28_Nya_1994_FC27R_328_V63;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-125
ModelArchive AF2\AF2_MSP2_clinical_isolates\29_Nyamisati_1994_Tanzania_lib12_Plate1_E4_ICR_638._V_66;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_29_Nya_1994_ICR_638_V66;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-126
ModelArchive AF2\AF2_MSP2_clinical_isolates\316_Nyamisati_1999_Tanzania_lib12_Plate4_D4_FC27R_376._V_69;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_316_Nya_1999_FC27R_376_V69;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-127
ModelArchive AF2\AF2_MSP2_clinical_isolates\343_Nyamisati_1994_Tanzania_lib12_Plate4_G7_ICR_605._V_75;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_343_Nya_1994_ICR_605_V75;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-128
ModelArchive AF2\AF2_MSP2_clinical_isolates\356_Nyamisati_1994_Tanzania_lib12_Plate4_D9_FC27R_376._V_79;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_356_Nya_1994_FC27R_376_V79;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-129
ModelArchive AF2\AF2_MSP2_clinical_isolates\359_Nyamisati_1994_Tanzania_lib12_Plate4_G9_FC27R_301._V_81;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_359_Nya_1994_FC27R_301_V81;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-130
ModelArchive AF2\AF2_MSP2_clinical_isolates\36_Nyamisati_1994_Tanzania_lib12_Plate1_D5_FC27R_256._V_87;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_36_Nya_1994_FC27R_256_V87;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-131
ModelArchive AF2\AF2_MSP2_clinical_isolates\362_Nyamisati_1994_Tanzania_lib12_Plate4_B10_FC27R_385._V_84;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_362_Nya_1994__FC27R_385_V84;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-132
ModelArchive AF2\AF2_MSP2_clinical_isolates\368_Nyamisati_1994_Tanzania_lib12_Plate4_H10_ICR_485._V_85;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_368_Nya_1994__ICR_485_V85;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-133
ModelArchive AF2\AF2_MSP2_clinical_isolates\368_Nyamisati_1994_Tanzania_lib12_Plate4_H10_ICR_566._V_86;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_368_Nya_1994__ICR_566_V86;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-134
ModelArchive AF2\AF2_MSP2_clinical_isolates\37_Nyamisati_1994_Tanzania_lib12_Plate1_E5_ICR_545._V_88;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_37_Nya_1994_ICR_545_V88;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-135
ModelArchive AF2\AF2_MSP2_clinical_isolates\384_Nyamisati_1999_Tanzania_lib12_Plate4_H12_ICR_572._V_91;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_384_Nya_1999__ICR_572_V91;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-136
ModelArchive AF2\AF2_MSP2_clinical_isolates\45_Nyamisati_1994_Tanzania_lib12_Plate1_E6_ICR_521._V_92;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_45_Nya_1994_ICR_521_V92;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-137
ModelArchive AF2\AF2_MSP2_clinical_isolates\45_Nyamisati_1994_Tanzania_lib12_Plate1_E6_ICR_575._V_93;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_45_Nya_1994_ICR_575_V93;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-138
ModelArchive AF2\AF2_MSP2_clinical_isolates\5_Nyamisati_1994_Tanzania_lib12_Plate1_E1_ICR_671._V_98;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_5_Nya_1994_ICR_671_V98;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-139
ModelArchive AF2\AF2_MSP2_clinical_isolates\52_Nyamisati_1994_Tanzania_lib12_Plate1_D7_FC27R_328._V_95;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_52_Nya_1994_FC27R_328_V95;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-140
ModelArchive AF2\AF2_MSP2_clinical_isolates\52_Nyamisati_1994_Tanzania_lib12_Plate1_D7_ICR_596._V_96;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_52_Nya_1994_ICR_596_V96;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-141
ModelArchive AF2\AF2_MSP2_clinical_isolates\53_Nyamisati_1994_Tanzania_lib12_Plate1_E7_ICR_557._V_97;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_53_Nya_1994_ICR_557_V97;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-142
ModelArchive AF2\AF2_MSP2_clinical_isolates\68_Nyamisati_1994_Tanzania_lib12_Plate1_D9_FC27R_220._V_102;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_68_Nya_1994_FC27R_220_V102;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-143
ModelArchive AF2\AF2_MSP2_clinical_isolates\69_Nyamisati_1994_Tanzania_lib12_Plate1_E9_ICR_503._V_103;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_69_Nya_1994_ICR_503_V103;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-144
ModelArchive AF2\AF2_MSP2_clinical_isolates\82_Nyamisati_2016_Tanzania_lib12_Plate1_B11_ICR_539._V_108;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_82_Nya_2016_ICR_539_V108;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-145
ModelArchive AF2\AF2_MSP2_clinical_isolates\84_Nyamisati_1994_Tanzania_lib12_Plate1_D11_FC27R_328._V_110;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_84_Nya_1994_FC27R_328_V110;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-146
ModelArchive AF2\AF2_MSP2_clinical_isolates\86_Nyamisati_1994_Tanzania_lib12_Plate1_F11_ICR_521._V_112;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_86_Nya_1994_ICR_521_V112;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-147
ModelArchive AF2\AF2_MSP2_clinical_isolates\87_Nyamisati_2016_Tanzania_lib12_Plate1_G11_ICR_515._V_113;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_87_Nya_2016_ICR_515_V113;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-148
ModelArchive AF2\AF2_MSP2_clinical_isolates\88_Nyamisati_2016_Tanzania_lib12_Plate1_H11_ICR_533._V_114;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_88_Nya_2016_ICR_533_V114;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-149
ModelArchive AF2\AF2_MSP2_clinical_isolates\9_Nyamisati_2016_Tanzania_lib12_Plate1_A2_FC27R_292._V_116;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_9_Nya_2016_FC27R_292_V116;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-150
ModelArchive AF2\AF2_MSP2_clinical_isolates\Alphafold2_Tz_1994_1_mmCIF_ranked_0;Alphafold 2.3.2+Galaxy3;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_Tz_1994_1;Model generated with Alphafold 2.3.2+Galaxy3 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-151
ModelArchive AF2\AF2_MSP2_clinical_isolates\1_10000_NF54_cultured_parasite_control_lib12_Plate1_E12_ICR_473._V_5;Alphafold 2.3.2+Galaxy2;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_NF54_cultured_parasite_ICR_473_V5;Model generated with Alphafold 2.3.2+Galaxy2 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-152
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_padlerig01_1_model_0;Alphafold3 (server);"Default; Seed Auto";PADL01_0205500;MSP2_padlerig01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PADL01_0205500) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFFI);MSP2 reference variant (PADL01_0205500) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFFI);N;1;880535;ma-csp-msp2-153
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_pbillcollinsig01_1_model_0;Alphafold3 (server);"Default; Seed Auto";PBILCG01_0209400;MSP2_pbillcollinsig01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PBILCG01_0209400) lacking its predicted signal peptide (MKVIKTLSIINLFIFVSLNISNESK) and GPI anchoring signal (NSSNMASINKFVALISATFVLAFAIFI);MSP2 reference variant (PBILCG01_0209400) lacking its predicted signal peptide (MKVIKTLSIINLFIFVSLNISNESK) and GPI anchoring signal (NSSNMASINKFVALISATFVLAFAIFI);N;1;720590;ma-csp-msp2-154
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_pblacklockig01_1_model_0;Alphafold3 (server);"Default; Seed Auto";PBLACG01_0203400;MSP2_pblacklockig01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PBLACG01_0203400) lacking its predicted signal peptide (MKVIKTLSIINFFIFVALNIKNESK) and GPI anchoring signal (SSSNIASINKFVALISATFVLAVSLFI);MSP2 reference variant (PBLACG01_0203400) lacking its predicted signal peptide (MKVIKTLSIINFFIFVALNIKNESK) and GPI anchoring signal (SSSNIASINKFVALISATFVLAVSLFI);N;1;880536;ma-csp-msp2-155
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pf3d7_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PF3D7_0206800;MSP2_pf3d7_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-156
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pf7g8_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";Pf7G8_020011500;MSP2_pf7g8_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-157
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfcd01_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfCD01_020011700;MSP2_pfcd01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-158
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfdd2_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfDd2_020009600;MSP2_pfdd2_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-159
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfgb4_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfGB4_020009800;MSP2_pfgb4_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-160
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfgn01_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfGN01_020012100;MSP2_pfgn01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-161
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfhb3_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfHB3_020011500;MSP2_pfhb3_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-162
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfke01_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfKE01_020009300;MSP2_pfke01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-163
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfsd01_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfSD01_020012300;MSP2_pfsd01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-164
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_pfsn01_msp2_1_model_0;Alphafold3 (server);"Default; Seed Auto";PfSN01_020009800;MSP2_pfsn01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PfDd2_020009600) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;5833;ma-csp-msp2-165
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_pgabonig01_1_model_0;Alphafold3 (server);"Default; Seed Auto";PGABG01_0204400;MSP2_pgabonig01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PGABG01_0204400) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFLI);MSP2 reference variant (PGABG01_0204400) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFLI);N;1;647221;ma-csp-msp2-166
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_pgabonisy75_1_model_0;Alphafold3 (server);"Default; Seed Auto";PGSY75_0206800;MSP2_pgabonisy75_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PGSY75_0206800) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFLI);MSP2 reference variant (PGSY75_0206800) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTLNIKNESK) and GPI anchoring signal (NSSNIASINNFVALISVTFVLAVSFLI);N;1;647221;ma-csp-msp2-167
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_ppraefalciparum_1_model_0;Alphafold3 (server);"Default; Seed Auto";PPRFG01_0206800;MSP2_ppraefalciparum_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PPRFG01_0206800) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);MSP2 reference variant (PPRFG01_0206800) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI);N;1;880534;ma-csp-msp2-168
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_preichenowi_1_model_0;Alphafold3 (server);"Default; Seed Auto";PRCDC_0205800;MSP2_preichenowi_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PRCDC_0205800) lacking its predicted signal peptide (MKVIKTLSIINFFIFLAFNIKNESK) and GPI anchoring signal (NSSNIASINKFVALISATLVLAFAIFI);MSP2 reference variant (PRCDC_0205800) lacking its predicted signal peptide (MKVIKTLSIINFFIFLAFNIKNESK) and GPI anchoring signal (NSSNIASINKFVALISATLVLAFAIFI);N;1;5854;ma-csp-msp2-169
ModelArchive AF3\AF3_MSP2_reference-variants-orthologs\fold_msp2_preichenowig01_1_model_0;Alphafold3 (server);"Default; Seed Auto";PRG01_0206000;MSP2_preichenowig01_1_model_0;Model generated with Alphafold3 (server) for MSP2 reference variant (PRG01_0206000) lacking its predicted signal peptide (MKVIKTLSIINFFIFVAFNIKNESK) and GPI anchoring signal (NSSNIASINKFVALISATLVLAFAIFI);MSP2 reference variant (PRG01_0206000) lacking its predicted signal peptide (MKVIKTLSIINFFIFVAFNIKNESK) and GPI anchoring signal (NSSNIASINKFVALISATLVLAFAIFI);N;1;5854;ma-csp-msp2-170
ModelArchive AF2\AF2_MSP2_clinical_isolates\Alphafold2_Trav_Uganda_4_mmCIF_ranked_0;Alphafold 2.3.2+Galaxy3;"Full database; training Cutoff 2021-09-30; Monomer; with Amber relaxation; Top5 ranked models. Other outputs generated: pLDDT and PAE matrix plots (per model); MSA sequence coverage plot; Per-model confidence scores; Per-residue confidence scores; ranked_*.pkl; relax_metrics.json; timings.json ";NA - Variant sequenced in clinical isolate;MSP2_Trav_Uganda_4;Model generated with Alphafold 2.3.2+Galaxy3 for a MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;MSP2 variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MKVIKTLSIINFFIFVTFNIKNESK) and GPI anchoring signal (NSSNIASINKFVVLISATLVLSFAIFI) ;N;1;5833;ma-csp-msp2-171
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_101_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_101_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-172
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_104_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_104_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-173
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_104_nyamisati_1999_3_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_104_Nya1999_3_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-174
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_114_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_114_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-175
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_116_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_116_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-176
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_119_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_119_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-177
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_122_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_122_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-178
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_122_nyamisati_1999_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_122_Nya1999_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-179
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_127_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_127_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-180
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_130_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_130_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-181
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_131_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_131_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-182
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_132_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_132_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-183
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_133_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_133_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-184
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_135_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_135_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-185
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_136_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_136_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-186
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_138_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_138_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-187
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_139_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_139_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-188
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_139_nyamisati_1994_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_139_Nya1994_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-189
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_140_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_140_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-190
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_141_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_141_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-191
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_142_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_142_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-192
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_143_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_143_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-193
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_144_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_144_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-194
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_155_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_155_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-195
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_160_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_160_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-196
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_17_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_17_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-197
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_184_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_184_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-198
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_188_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_188_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-199
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_193_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_193_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-200
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_196_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_196_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-201
ModelArchive AF3\AF3_CSP_CIS43variable\fold_197_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_197_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-202
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_202_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_202_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-203
ModelArchive AF3\AF3_CSP_CIS43variable\fold_205_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_205_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-204
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_208_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_208_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-205
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_21_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_21_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-206
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_219_nyamisati_2016_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_219_Nya2016_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-207
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_22_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_22_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-208
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_221_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_221_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-209
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_222_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_222_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-210
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_223_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_223_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-211
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_224_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_224_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-212
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_23_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_23_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-213
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_251_nyamisati_2016_1_1_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_251_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-214
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_252_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_252_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-215
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_257_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_257_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-216
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_259_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_259_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-217
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_276_nyamisati_1994_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_276_Nya1994_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-218
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_298_nyamisati_1999_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_298_Nya1999_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-219
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_301_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_301_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-220
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_301_nyamisati_1999_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_301_Nya1999_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-221
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_315_nyamisati_1999_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_315_Nya1999_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-222
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_33_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_33_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-223
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_34_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_34_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-224
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_341_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_341_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-225
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_357_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_357_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-226
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_37_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_37_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-227
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_38_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_38_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-228
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_3d7_bound_cis43_variable_only_model_0;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-229
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_3d7_bound_cis43_variable_only_model_1;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_mAbCIS43_model_1;Model generated with Alphafold3 (server) for a Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;2;5833;ma-csp-msp2-230
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_3d7_bound_cis43_variable_only_model_2;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_mAbCIS43_model_2;Model generated with Alphafold3 (server) for a Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;3;5833;ma-csp-msp2-231
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_3d7_bound_cis43_variable_only_model_3;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_mAbCIS43_model_3;Model generated with Alphafold3 (server) for a Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;4;5833;ma-csp-msp2-232
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_3d7_bound_cis43_variable_only_model_4;Alphafold3 (server);"Default; Seed Auto";PF3D7_0304600;CSP_3d7_mAbCIS43_model_4;Model generated with Alphafold3 (server) for a Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 3D7 (PF3D7_0304600) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;5;5833;ma-csp-msp2-233
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_41_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_41_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-234
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_42_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_42_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-235
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_44_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_44_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-236
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_44_nyamisati_1994_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_44_Nya1994_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-237
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_46_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_46_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-238
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_47_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_47_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-239
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_48_nyamisati_1994_3_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_48_Nya1994_3_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-240
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_48_nyamisati_1994_4_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_48_Nya1994_4_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-241
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_58_nyamisati_2016_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_58_Nya2016_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-242
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_58_nyamisati_2016_4_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_58_Nya2016_4_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-243
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_62_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_62_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-244
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_64_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_64_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-245
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_7g8_bound_cis43_igg1_model_0;Alphafold3 (server);"Default; Seed Auto";Pf7G8-2_000074100;CSP_7g8_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-246
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_81_nyamisati_2016_2_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_81_Nya2016_2_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-247
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_86_nyamisati_1994_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_86_Nya1994_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-248
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_88_nyamisati_2016_1_1_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";NA - Variant sequenced in clinical isolate;CSP_88_Nya2016_1_1_mAbCIS43_model_0;Model generated with Alphafold3 (server) for a CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);CSP variant sequenced as part of Plaza DF et al 2023 (PMID: 37751696) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-249
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_gn01_bound_cis43_igg1_model_0;Alphafold3 (server);"Default; Seed Auto";PfGN01_030010200;CSP_gn01_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-250
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_ke01_bound_cis43_igg1_model_0;Alphafold3 (server);"Default; Seed Auto";PfKE01_030009000;CSP_ke01_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-251
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_nf166_bound_cis43_igg1_model_0;Alphafold3 (server);"Default; Seed Auto";PfNF166_030008000;CSP_nf166_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-252
ModelArchive AF3\AF3_CSP_CIS43variable\fold_csp_tg01_bound_cis43_igg1_model_0;Alphafold3 (server);"Default; Seed Auto";PfTG01_030011000;CSP_tg01_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference CSP variant 7G8 (Pf7G8-2_000074100) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-253
ModelArchive AF3\AF3_CSP_CIS43variable\fold_msp2_3d7_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";PF3D7_0206800;MSP2_3d7_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Reference MSP2 variant 3D7 (PF3D7_0206800) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Reference MSP2 variant 3D7 (PF3D7_0206800) lacking its predicted signal peptide (MMRKLAILSVSSFLFVEA) and GPI anchoring signal (CSSVFNVVNSSIGLIMVLSFLFLN);Y;1;5833;ma-csp-msp2-254
ModelArchive AF3\AF3_CSP_CIS43variable\fold_ova_bound_cis43_variable_model_0;Alphafold3 (server);"Default; Seed Auto";UP - P01012;OVA_mAbCIS43_model_0;Model generated with Alphafold3 (server) for Ovalbumin (UniProt P01012) in the presence of domains VL and VH from monoclonal antibody CIS43 (PMID: 29554083);Ovalbumin (UniProt P01012);Y;1;9031;ma-csp-msp2-255
